May 2, 2018 / 11:38 AM / in 2 months

BRIEF-Insmed Reports Q1 Loss Per Share $0.89

May 2 (Reuters) - Insmed Inc:

* INSMED REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.89

* Q1 EARNINGS PER SHARE VIEW $-0.98 — THOMSON REUTERS I/B/E/S

* PREPARING FOR POTENTIAL PRODUCT LAUNCH OF ALIS IN 4Q 2018

* SUBMITTED NDA TO FDA FOR AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) IN NTM LUNG DISEASE CAUSED BY MAC; ANTICIPATES PRIORITY REVIEW

* AS OF MARCH 31, 2018, INSMED HAD CASH AND CASH EQUIVALENTS OF $686.6 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below